Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-06465469

Copy Product Info
😃Good
Catalog No. T16493Cas No. 1407966-77-1
Alias PF06465469, PF 06465469

PF-06465469 is a covalent ITK inhibitor (IC₅₀ = 2 nM) that also inhibits BTK. PF-06465469 suppresses CXCL12-mediated cell migration, decreases PD-1 and LAG-3 expression. PF-06465469 shows strong potential application in leukemia and T-cell lymphoma research.

PF-06465469

PF-06465469

Copy Product Info
😃Good
Catalog No. T16493Alias PF06465469, PF 06465469Cas No. 1407966-77-1
PF-06465469 is a covalent ITK inhibitor (IC₅₀ = 2 nM) that also inhibits BTK. PF-06465469 suppresses CXCL12-mediated cell migration, decreases PD-1 and LAG-3 expression. PF-06465469 shows strong potential application in leukemia and T-cell lymphoma research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$45-In Stock
5 mg$106-In Stock
10 mg$179-In Stock
25 mg$392-In Stock
1 mL x 10 mM (in DMSO)$123-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PF-06465469 is a covalent ITK inhibitor (IC₅₀ = 2 nM) that also inhibits BTK. PF-06465469 suppresses CXCL12-mediated cell migration, decreases PD-1 and LAG-3 expression. PF-06465469 shows strong potential application in leukemia and T-cell lymphoma research.
Targets&IC50
ITK:2 nM
In vitro
Treatment of Jurkat cells with 2 µM PF-06465469 for 24 hours reduced intracellular ITK phosphorylation levels and inhibited the migratory response of Jurkat cells to CXCL12 [1].
When the concentration of PF-06465469 was 1 µM, it significantly downregulated the expression levels of CD69, PD-1, and LAG-3 molecules in CAR-T cells co-cultured with MEC1 cells [2].
SynonymsPF06465469, PF 06465469
Chemical Properties
Molecular Weight523.63
FormulaC30H33N7O2
Cas No.1407966-77-1
SmilesNC1=C2C(=NN(C2=NC=N1)[C@H]3CN(C(C=C)=O)CCC3)C4=CC(C(NC5=CC(C)=C(C(C)C)C=C5)=O)=CC=C4
Relative Density.1.30 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 8.5 mg/mL (16.23 mM), Sonication is recommeded.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9097 mL9.5487 mL19.0975 mL95.4873 mL
5 mM0.3819 mL1.9097 mL3.8195 mL19.0975 mL
10 mM0.1910 mL0.9549 mL1.9097 mL9.5487 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-06465469 | purchase PF-06465469 | PF-06465469 cost | order PF-06465469 | PF-06465469 chemical structure | PF-06465469 in vitro | PF-06465469 formula | PF-06465469 molecular weight